'No shortage of medicines to combat COVID-19'

Image
ANI General News
Last Updated : Mar 31 2020 | 8:15 PM IST

The Department of Pharmaceuticals, under Ministry of Chemicals and Fertilisers, is continuously monitoring the distribution and addressing issues of availability, supply and local related issues of medicines with the help of other departments, states and Union Territories (UTs).

A central control room (011-23389840) has been set up in the Department of Pharmaceuticals, which is working from 8 am to 6 pm, read a statement.

The National Pharmaceutical Pricing Authority (NPPA) has set up another control room - helpline number 1800111255 - which functions round the clock. The control rooms deal with issues related to queries and complaints and messages dealing with COVID-19 as well as coordination of transport and other logistic services related to drugs and medical devices.

The Department of Pharmaceuticals is working in close coordination with line departments like Ministry of Health and Family Welfare, Ministry of Commerce and Industry, customs authorities, Central and State Drug Controllers, state governments, UTs, and various drugs and medical device associations, the statement added.

Also, it is continuously monitoring the production of medicines since the outbreak of coronavirus in China. After the lockdown, the department is facilitating the industry by addressing various issues arising from time to time as quickly as possible on top priority in consultation with various authorities including state and Union Territory governments.

"In case any issue pertaining to other Ministries/Departments comes or are brought to DoPs attention, the same is being flagged to the authorities concerned as a part of inter-departmental coordination and through empowered groups," it said.

The NPPA has directed manufacturers to produce and maintain sufficient stocks of essential drugs at any point of time. All efforts are made to ensure the production of drugs and medical devices during the period of lockdown, the statement added.

The Department of Pharmaceuticals is using digital platforms forming WhatsApp groups/email systems and using video conferencing facilities to ensure prompt action at various levels.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 31 2020 | 8:01 PM IST

Next Story